FDA Approves Unknown Drug — DR REDDYS

# FDA Approves Dr. Reddy's Generic Drug Application Dr. Reddy's Laboratories has received FDA approval for ANDA220315, marking another addition to the company's generic drug portfolio and positioning it to capture market share in a competitive therapeutic segment. The approval strengthens Dr. Reddy's presence in the U.S. generics market, where the company competes intensely with other manufacturers to meet growing demand for cost-effective pharmaceutical alternatives.